Patent · US Active

NK-3 receptor antagonists for therapeutic or cosmetic treatment of excess body fat

US10624890B2 · kind B2 · utility

0Cited by

4References

10Claims

0Family size

Assignee

Ogeda SA · BE

Inventors

Hamid R. Hoveyda · Brussels, BE
Graeme L. Fraser · Bousval, BE

Key dates

Filing date	Mar 16, 2016
Grant date	Apr 21, 2020
Priority date	—
Expiry date	Mar 16, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P3/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is use of NK3R antagonists for the therapeutic treatment of pathological excess body fat and/or prevention of body fat gain in patients. Also disclosed is a cosmetic method for stimulating the loss of excess of body fat, including the administration of a NK-3 receptor antagonist.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.